ZTS Zoetis Inc

Price (delayed)

$165.18

Market cap

$76.99B

P/E Ratio

37.63

Dividend/share

$1.35

EPS

$4.39

Enterprise value

$81.23B

Zoetis Inc. is the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's ...

Highlights
The P/E is 13% lower than the last 4 quarters average of 43.2 and 9% lower than the 5-year quarterly average of 41.2
The gross profit has grown by 6% YoY
Zoetis's quick ratio has shrunk by 57% YoY

Key stats

What are the main financial stats of ZTS
Market
Shares outstanding
466.07M
Market cap
$76.99B
Enterprise value
$81.23B
Valuations
Price to earnings (P/E)
37.63
Price to book (P/B)
16.58
Price to sales (P/S)
9.65
EV/EBIT
29.16
EV/EBITDA
25
EV/Sales
10.14
Earnings
Revenue
$8.01B
EBIT
$2.79B
EBITDA
$3.25B
Free cash flow
$1.27B
Per share
EPS
$4.39
Free cash flow per share
$2.71
Book value per share
$9.96
Revenue per share
$17.12
TBVPS
$20.66
Balance sheet
Total assets
$13.67B
Total liabilities
$9.01B
Debt
$6.75B
Equity
$4.66B
Working capital
$3.67B
Liquidity
Debt to equity
1.45
Current ratio
2.27
Quick ratio
1.28
Net debt/EBITDA
1.31
Margins
EBITDA margin
40.6%
Gross margin
70%
Net margin
25.8%
Operating margin
34.8%
Efficiency
Return on assets
15%
Return on equity
44.8%
Return on invested capital
25.8%
Return on capital employed
25.8%
Return on sales
34.8%
Dividend
Dividend yield
0.82%
DPS
$1.35
Payout ratio
30.8%

ZTS stock price

How has the Zoetis stock price performed over time
Intraday
-1.82%
1 week
0.84%
1 month
13.68%
1 year
-11.98%
YTD
12.71%
QTD
12.71%

Financial performance

How have Zoetis's revenue and profit performed over time
Revenue
$8.01B
Gross profit
$5.61B
Operating income
$2.78B
Net income
$2.07B
Gross margin
70%
Net margin
25.8%
The gross profit has grown by 6% YoY
Zoetis's operating income has increased by 6% YoY
ZTS's revenue is up by 5% YoY
The net income has grown by 4.3% YoY

Growth

What is Zoetis's growth rate over time

Valuation

What is Zoetis stock price valuation
P/E
37.63
P/B
16.58
P/S
9.65
EV/EBIT
29.16
EV/EBITDA
25
EV/Sales
10.14
The P/E is 13% lower than the last 4 quarters average of 43.2 and 9% lower than the 5-year quarterly average of 41.2
Zoetis's EPS has increased by 5% YoY
The stock's price to book (P/B) is 19% less than its 5-year quarterly average of 20.5 and 14% less than its last 4 quarters average of 19.3
ZTS's price to sales (P/S) is 14% lower than its last 4 quarters average of 11.2 and 3.5% lower than its 5-year quarterly average of 10.0
ZTS's revenue is up by 5% YoY

Efficiency

How efficient is Zoetis business performance
ZTS's ROIC is up by 9% YoY
The company's return on equity fell by 4.5% YoY
ZTS's return on assets is up by 4.2% year-on-year

Dividends

What is ZTS's dividend history
DPS
$1.35
Dividend yield
0.82%
Payout ratio
30.8%
Recent dividends

Financial health

How did Zoetis financials performed over time
ZTS's total assets is 52% greater than its total liabilities
Zoetis's quick ratio has shrunk by 57% YoY
The company's current ratio has shrunk by 50% YoY but it rose by 4.1% QoQ
The debt is 45% higher than the equity

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.